COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS RELATED TO DOSING IN CELL THERAPY

Provided herein are methods, compositions and articles of manufacture for use in connection with cell therapy involving the administration of one or more doses of a therapeutic T cell composition. The cells of the T cell composition express recombinant receptors such as chimeric receptors, e.g. chim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GILBERT, MARK, WHITMORE, JAMES BOYD, CHARTRAND, NATHANIEL, BEAUCHESNE, PASCAL, YEE, NATHAN, TREDE, NIKOLAUS SEBASTIAN, COVINGTON, MICHAEL GERARD, RAMSBORG, CHRISTOPHER GLEN, LAMBERT, NATHANIEL, DAVIS-PICKETT, MEL, LI, HE, SMITH, JEFF, GETTO, RICHARD JAMES, WEBER, CLINTON, POLLOCK, KATHRYN LINDSAY, BECKETT, TRAVIS, CHRISTIN, BRIAN, LARSON, RYAN P, ODEGARD, VALERIE, SUTHERLAND, CLAIRE, WALKER, ANDREW W, DAVE, KEDAR HIMANSHU, BLACKMAN, SAMUEL CHARLES, MALLANEY, MARY, KOWSKI, TOM
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GILBERT, MARK
WHITMORE, JAMES BOYD
CHARTRAND, NATHANIEL
BEAUCHESNE, PASCAL
YEE, NATHAN
TREDE, NIKOLAUS SEBASTIAN
COVINGTON, MICHAEL GERARD
RAMSBORG, CHRISTOPHER GLEN
LAMBERT, NATHANIEL
DAVIS-PICKETT, MEL
LI, HE
SMITH, JEFF
GETTO, RICHARD JAMES
WEBER, CLINTON
POLLOCK, KATHRYN LINDSAY
BECKETT, TRAVIS
CHRISTIN, BRIAN
LARSON, RYAN P
ODEGARD, VALERIE
SUTHERLAND, CLAIRE
WALKER, ANDREW W
DAVE, KEDAR HIMANSHU
BLACKMAN, SAMUEL CHARLES
MALLANEY, MARY
KOWSKI, TOM
description Provided herein are methods, compositions and articles of manufacture for use in connection with cell therapy involving the administration of one or more doses of a therapeutic T cell composition. The cells of the T cell composition express recombinant receptors such as chimeric receptors, e.g. chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). Features of the provided embodiments, including the numbers of cells or units of cells administered and/or the potency of administered cells, provide various advantages, such as lower risk of toxicity in subjects administered the T cell compositions. L'invention concerne des méthodes, des compositions et des articles manufacturés destinés à être utilisés dans le cadre d'une thérapie cellulaire impliquant l'administration d'une ou de plusieurs doses d'une composition de lymphocytes T thérapeutique. Les cellules de la composition de lymphocytes T expriment des récepteurs recombinés tels que des récepteurs chimériques, p. ex. des récepteurs antigéniques chimériques (CAR) ou autres récepteurs transgéniques, tels que des récepteurs de lymphocytes T (TCR). Les caractéristiques des modes de réalisation décrits, dont les nombres de cellules ou d'unités de cellules administrés et/ou la puissance des cellules administrées, procurent divers avantages, tels qu'un risque moins élevé de toxicité chez les sujets recevant lesdites compositions de lymphocytes T.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3053539A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3053539A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3053539A13</originalsourceid><addsrcrecordid>eNqNyz0KAjEQQOE0FqLeYQ6goIQtLIfJxATysySzhdWySKxEF9b7o4UHsHrN99aqUo59rl58TnUPWMRT4ArZQsQ0WCQZCgMmA5HFZVOhcEBhA5LBfM90AZ-AOAQQxwX761at7tNjabtfNwosC7lDm19jW-bp1p7tPRLqY6c7fcaT_oN8AJiALzU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS RELATED TO DOSING IN CELL THERAPY</title><source>esp@cenet</source><creator>GILBERT, MARK ; WHITMORE, JAMES BOYD ; CHARTRAND, NATHANIEL ; BEAUCHESNE, PASCAL ; YEE, NATHAN ; TREDE, NIKOLAUS SEBASTIAN ; COVINGTON, MICHAEL GERARD ; RAMSBORG, CHRISTOPHER GLEN ; LAMBERT, NATHANIEL ; DAVIS-PICKETT, MEL ; LI, HE ; SMITH, JEFF ; GETTO, RICHARD JAMES ; WEBER, CLINTON ; POLLOCK, KATHRYN LINDSAY ; BECKETT, TRAVIS ; CHRISTIN, BRIAN ; LARSON, RYAN P ; ODEGARD, VALERIE ; SUTHERLAND, CLAIRE ; WALKER, ANDREW W ; DAVE, KEDAR HIMANSHU ; BLACKMAN, SAMUEL CHARLES ; MALLANEY, MARY ; KOWSKI, TOM</creator><creatorcontrib>GILBERT, MARK ; WHITMORE, JAMES BOYD ; CHARTRAND, NATHANIEL ; BEAUCHESNE, PASCAL ; YEE, NATHAN ; TREDE, NIKOLAUS SEBASTIAN ; COVINGTON, MICHAEL GERARD ; RAMSBORG, CHRISTOPHER GLEN ; LAMBERT, NATHANIEL ; DAVIS-PICKETT, MEL ; LI, HE ; SMITH, JEFF ; GETTO, RICHARD JAMES ; WEBER, CLINTON ; POLLOCK, KATHRYN LINDSAY ; BECKETT, TRAVIS ; CHRISTIN, BRIAN ; LARSON, RYAN P ; ODEGARD, VALERIE ; SUTHERLAND, CLAIRE ; WALKER, ANDREW W ; DAVE, KEDAR HIMANSHU ; BLACKMAN, SAMUEL CHARLES ; MALLANEY, MARY ; KOWSKI, TOM</creatorcontrib><description>Provided herein are methods, compositions and articles of manufacture for use in connection with cell therapy involving the administration of one or more doses of a therapeutic T cell composition. The cells of the T cell composition express recombinant receptors such as chimeric receptors, e.g. chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). Features of the provided embodiments, including the numbers of cells or units of cells administered and/or the potency of administered cells, provide various advantages, such as lower risk of toxicity in subjects administered the T cell compositions. L'invention concerne des méthodes, des compositions et des articles manufacturés destinés à être utilisés dans le cadre d'une thérapie cellulaire impliquant l'administration d'une ou de plusieurs doses d'une composition de lymphocytes T thérapeutique. Les cellules de la composition de lymphocytes T expriment des récepteurs recombinés tels que des récepteurs chimériques, p. ex. des récepteurs antigéniques chimériques (CAR) ou autres récepteurs transgéniques, tels que des récepteurs de lymphocytes T (TCR). Les caractéristiques des modes de réalisation décrits, dont les nombres de cellules ou d'unités de cellules administrés et/ou la puissance des cellules administrées, procurent divers avantages, tels qu'un risque moins élevé de toxicité chez les sujets recevant lesdites compositions de lymphocytes T.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180830&amp;DB=EPODOC&amp;CC=CA&amp;NR=3053539A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180830&amp;DB=EPODOC&amp;CC=CA&amp;NR=3053539A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GILBERT, MARK</creatorcontrib><creatorcontrib>WHITMORE, JAMES BOYD</creatorcontrib><creatorcontrib>CHARTRAND, NATHANIEL</creatorcontrib><creatorcontrib>BEAUCHESNE, PASCAL</creatorcontrib><creatorcontrib>YEE, NATHAN</creatorcontrib><creatorcontrib>TREDE, NIKOLAUS SEBASTIAN</creatorcontrib><creatorcontrib>COVINGTON, MICHAEL GERARD</creatorcontrib><creatorcontrib>RAMSBORG, CHRISTOPHER GLEN</creatorcontrib><creatorcontrib>LAMBERT, NATHANIEL</creatorcontrib><creatorcontrib>DAVIS-PICKETT, MEL</creatorcontrib><creatorcontrib>LI, HE</creatorcontrib><creatorcontrib>SMITH, JEFF</creatorcontrib><creatorcontrib>GETTO, RICHARD JAMES</creatorcontrib><creatorcontrib>WEBER, CLINTON</creatorcontrib><creatorcontrib>POLLOCK, KATHRYN LINDSAY</creatorcontrib><creatorcontrib>BECKETT, TRAVIS</creatorcontrib><creatorcontrib>CHRISTIN, BRIAN</creatorcontrib><creatorcontrib>LARSON, RYAN P</creatorcontrib><creatorcontrib>ODEGARD, VALERIE</creatorcontrib><creatorcontrib>SUTHERLAND, CLAIRE</creatorcontrib><creatorcontrib>WALKER, ANDREW W</creatorcontrib><creatorcontrib>DAVE, KEDAR HIMANSHU</creatorcontrib><creatorcontrib>BLACKMAN, SAMUEL CHARLES</creatorcontrib><creatorcontrib>MALLANEY, MARY</creatorcontrib><creatorcontrib>KOWSKI, TOM</creatorcontrib><title>COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS RELATED TO DOSING IN CELL THERAPY</title><description>Provided herein are methods, compositions and articles of manufacture for use in connection with cell therapy involving the administration of one or more doses of a therapeutic T cell composition. The cells of the T cell composition express recombinant receptors such as chimeric receptors, e.g. chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). Features of the provided embodiments, including the numbers of cells or units of cells administered and/or the potency of administered cells, provide various advantages, such as lower risk of toxicity in subjects administered the T cell compositions. L'invention concerne des méthodes, des compositions et des articles manufacturés destinés à être utilisés dans le cadre d'une thérapie cellulaire impliquant l'administration d'une ou de plusieurs doses d'une composition de lymphocytes T thérapeutique. Les cellules de la composition de lymphocytes T expriment des récepteurs recombinés tels que des récepteurs chimériques, p. ex. des récepteurs antigéniques chimériques (CAR) ou autres récepteurs transgéniques, tels que des récepteurs de lymphocytes T (TCR). Les caractéristiques des modes de réalisation décrits, dont les nombres de cellules ou d'unités de cellules administrés et/ou la puissance des cellules administrées, procurent divers avantages, tels qu'un risque moins élevé de toxicité chez les sujets recevant lesdites compositions de lymphocytes T.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyz0KAjEQQOE0FqLeYQ6goIQtLIfJxATysySzhdWySKxEF9b7o4UHsHrN99aqUo59rl58TnUPWMRT4ArZQsQ0WCQZCgMmA5HFZVOhcEBhA5LBfM90AZ-AOAQQxwX761at7tNjabtfNwosC7lDm19jW-bp1p7tPRLqY6c7fcaT_oN8AJiALzU</recordid><startdate>20180830</startdate><enddate>20180830</enddate><creator>GILBERT, MARK</creator><creator>WHITMORE, JAMES BOYD</creator><creator>CHARTRAND, NATHANIEL</creator><creator>BEAUCHESNE, PASCAL</creator><creator>YEE, NATHAN</creator><creator>TREDE, NIKOLAUS SEBASTIAN</creator><creator>COVINGTON, MICHAEL GERARD</creator><creator>RAMSBORG, CHRISTOPHER GLEN</creator><creator>LAMBERT, NATHANIEL</creator><creator>DAVIS-PICKETT, MEL</creator><creator>LI, HE</creator><creator>SMITH, JEFF</creator><creator>GETTO, RICHARD JAMES</creator><creator>WEBER, CLINTON</creator><creator>POLLOCK, KATHRYN LINDSAY</creator><creator>BECKETT, TRAVIS</creator><creator>CHRISTIN, BRIAN</creator><creator>LARSON, RYAN P</creator><creator>ODEGARD, VALERIE</creator><creator>SUTHERLAND, CLAIRE</creator><creator>WALKER, ANDREW W</creator><creator>DAVE, KEDAR HIMANSHU</creator><creator>BLACKMAN, SAMUEL CHARLES</creator><creator>MALLANEY, MARY</creator><creator>KOWSKI, TOM</creator><scope>EVB</scope></search><sort><creationdate>20180830</creationdate><title>COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS RELATED TO DOSING IN CELL THERAPY</title><author>GILBERT, MARK ; WHITMORE, JAMES BOYD ; CHARTRAND, NATHANIEL ; BEAUCHESNE, PASCAL ; YEE, NATHAN ; TREDE, NIKOLAUS SEBASTIAN ; COVINGTON, MICHAEL GERARD ; RAMSBORG, CHRISTOPHER GLEN ; LAMBERT, NATHANIEL ; DAVIS-PICKETT, MEL ; LI, HE ; SMITH, JEFF ; GETTO, RICHARD JAMES ; WEBER, CLINTON ; POLLOCK, KATHRYN LINDSAY ; BECKETT, TRAVIS ; CHRISTIN, BRIAN ; LARSON, RYAN P ; ODEGARD, VALERIE ; SUTHERLAND, CLAIRE ; WALKER, ANDREW W ; DAVE, KEDAR HIMANSHU ; BLACKMAN, SAMUEL CHARLES ; MALLANEY, MARY ; KOWSKI, TOM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3053539A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GILBERT, MARK</creatorcontrib><creatorcontrib>WHITMORE, JAMES BOYD</creatorcontrib><creatorcontrib>CHARTRAND, NATHANIEL</creatorcontrib><creatorcontrib>BEAUCHESNE, PASCAL</creatorcontrib><creatorcontrib>YEE, NATHAN</creatorcontrib><creatorcontrib>TREDE, NIKOLAUS SEBASTIAN</creatorcontrib><creatorcontrib>COVINGTON, MICHAEL GERARD</creatorcontrib><creatorcontrib>RAMSBORG, CHRISTOPHER GLEN</creatorcontrib><creatorcontrib>LAMBERT, NATHANIEL</creatorcontrib><creatorcontrib>DAVIS-PICKETT, MEL</creatorcontrib><creatorcontrib>LI, HE</creatorcontrib><creatorcontrib>SMITH, JEFF</creatorcontrib><creatorcontrib>GETTO, RICHARD JAMES</creatorcontrib><creatorcontrib>WEBER, CLINTON</creatorcontrib><creatorcontrib>POLLOCK, KATHRYN LINDSAY</creatorcontrib><creatorcontrib>BECKETT, TRAVIS</creatorcontrib><creatorcontrib>CHRISTIN, BRIAN</creatorcontrib><creatorcontrib>LARSON, RYAN P</creatorcontrib><creatorcontrib>ODEGARD, VALERIE</creatorcontrib><creatorcontrib>SUTHERLAND, CLAIRE</creatorcontrib><creatorcontrib>WALKER, ANDREW W</creatorcontrib><creatorcontrib>DAVE, KEDAR HIMANSHU</creatorcontrib><creatorcontrib>BLACKMAN, SAMUEL CHARLES</creatorcontrib><creatorcontrib>MALLANEY, MARY</creatorcontrib><creatorcontrib>KOWSKI, TOM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GILBERT, MARK</au><au>WHITMORE, JAMES BOYD</au><au>CHARTRAND, NATHANIEL</au><au>BEAUCHESNE, PASCAL</au><au>YEE, NATHAN</au><au>TREDE, NIKOLAUS SEBASTIAN</au><au>COVINGTON, MICHAEL GERARD</au><au>RAMSBORG, CHRISTOPHER GLEN</au><au>LAMBERT, NATHANIEL</au><au>DAVIS-PICKETT, MEL</au><au>LI, HE</au><au>SMITH, JEFF</au><au>GETTO, RICHARD JAMES</au><au>WEBER, CLINTON</au><au>POLLOCK, KATHRYN LINDSAY</au><au>BECKETT, TRAVIS</au><au>CHRISTIN, BRIAN</au><au>LARSON, RYAN P</au><au>ODEGARD, VALERIE</au><au>SUTHERLAND, CLAIRE</au><au>WALKER, ANDREW W</au><au>DAVE, KEDAR HIMANSHU</au><au>BLACKMAN, SAMUEL CHARLES</au><au>MALLANEY, MARY</au><au>KOWSKI, TOM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS RELATED TO DOSING IN CELL THERAPY</title><date>2018-08-30</date><risdate>2018</risdate><abstract>Provided herein are methods, compositions and articles of manufacture for use in connection with cell therapy involving the administration of one or more doses of a therapeutic T cell composition. The cells of the T cell composition express recombinant receptors such as chimeric receptors, e.g. chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). Features of the provided embodiments, including the numbers of cells or units of cells administered and/or the potency of administered cells, provide various advantages, such as lower risk of toxicity in subjects administered the T cell compositions. L'invention concerne des méthodes, des compositions et des articles manufacturés destinés à être utilisés dans le cadre d'une thérapie cellulaire impliquant l'administration d'une ou de plusieurs doses d'une composition de lymphocytes T thérapeutique. Les cellules de la composition de lymphocytes T expriment des récepteurs recombinés tels que des récepteurs chimériques, p. ex. des récepteurs antigéniques chimériques (CAR) ou autres récepteurs transgéniques, tels que des récepteurs de lymphocytes T (TCR). Les caractéristiques des modes de réalisation décrits, dont les nombres de cellules ou d'unités de cellules administrés et/ou la puissance des cellules administrées, procurent divers avantages, tels qu'un risque moins élevé de toxicité chez les sujets recevant lesdites compositions de lymphocytes T.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3053539A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS RELATED TO DOSING IN CELL THERAPY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T05%3A54%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GILBERT,%20MARK&rft.date=2018-08-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3053539A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true